170 related articles for article (PubMed ID: 26082438)
1. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study.
Novo S; Peritore A; Guarneri FP; Corrado E; Macaione F; Evola S; Novo G
Atherosclerosis; 2012 Aug; 223(2):468-72. PubMed ID: 22704563
[TBL] [Abstract][Full Text] [Related]
3. Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting.
Davies MG; Saad WE; Bismuth J; Naoum JJ; Peden EK; Lumsden AB
J Vasc Surg; 2010 Apr; 51(4):926-32. PubMed ID: 20022208
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.
Younis A; Younis A; Tzur B; Peled Y; Shlomo N; Goldenberg I; Fisman EZ; Tenenbaum A; Klempfner R
Cardiovasc Diabetol; 2016 Oct; 15(1):149. PubMed ID: 27793156
[TBL] [Abstract][Full Text] [Related]
6. Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India.
Prasad N; Sinha A; Gupta A; Sharma RK; Kaul A; Bhadauria D; Ranagswamy D
Nephrology (Carlton); 2013 Oct; 18(10):657-64. PubMed ID: 23834643
[TBL] [Abstract][Full Text] [Related]
7. Determinants of survival after liver resection for metastatic colorectal carcinoma.
Parau A; Todor N; Vlad L
J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
[TBL] [Abstract][Full Text] [Related]
8. Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.
Wassink AM; van der Graaf Y; Janssen KJ; Cook NR; Visseren FL;
Eur J Prev Cardiol; 2012 Dec; 19(6):1486-95. PubMed ID: 22008749
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization.
Protack CD; Bakken AM; Xu J; Saad WA; Lumsden AB; Davies MG
J Vasc Surg; 2009 May; 49(5):1172-80.e1; discussion 1180. PubMed ID: 19394545
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.
Diamantis N; Xynos ID; Amptulah S; Karadima M; Skopelitis H; Tsavaris N
J BUON; 2013; 18(1):105-15. PubMed ID: 23613395
[TBL] [Abstract][Full Text] [Related]
11. The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer Patients.
Lin HH; Yang HL; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Chen WS; Liang WY; Chang SC
Hepatogastroenterology; 2014 Jun; 61(132):1024-7. PubMed ID: 26158160
[TBL] [Abstract][Full Text] [Related]
12. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study.
Yang T; Chu CH; Bai CH; You SL; Chou YC; Chou WY; Chien KL; Hwang LC; Su TC; Tseng CH; Sun CA
Atherosclerosis; 2012 Feb; 220(2):525-31. PubMed ID: 22154195
[TBL] [Abstract][Full Text] [Related]
13. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
Taylor FG; Quirke P; Heald RJ; Moran BJ; Blomqvist L; Swift IR; Sebag-Montefiore D; Tekkis P; Brown G;
J Clin Oncol; 2014 Jan; 32(1):34-43. PubMed ID: 24276776
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis.
You J; Huang S; Huang GQ; Zhu GQ; Ma RM; Liu WY; Shi KQ; Guo GL; Chen YP; Braddock M; Zheng MH
Medicine (Baltimore); 2015 Feb; 94(5):e479. PubMed ID: 25654388
[TBL] [Abstract][Full Text] [Related]
16. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
[TBL] [Abstract][Full Text] [Related]
17. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
[TBL] [Abstract][Full Text] [Related]
18. Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?
Ozturk MA; Dane F; Karagoz S; Tural D; Selcukbiricik F; Demirelli F; Buyukunal E; Ozguroglu M; Turna H; Erdamar S; Celikel CA; Bozkurtlar EB; Yumuk PF; Mandel NM; Turhal NS; Serdengecti S
Hepatogastroenterology; 2015; 62(137):59-64. PubMed ID: 25911868
[TBL] [Abstract][Full Text] [Related]
19. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
20. Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: the 'obesity paradox' phenomenon is still apparent.
Patsa C; Toutouzas K; Tsiamis E; Tsioufis C; Spanos A; Karanasos A; Michelongona A; Tousoulis D; Stefanadis C
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):307-13. PubMed ID: 21917434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
